HIMCH
EGRX

Hartford Investment Management Co (HIMCO)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,420
Closed -$259K – 693
2018
Q4 		$259K Hold
6,420
– – 0.01% 606
2018
Q3 		$445K Sell
6,420
-428
-6% -$32.4K 0.01% 546
2018
Q2 		$518K Buy
+6,848
New +$431K 0.02% 536

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s EGRX Position: Q1 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2019, closing a stake of 6,420 shares — an estimated $259K sold.

Hartford Investment Management Co (HIMCO) first reported a position in EGRX in Q2 2018 and held it in 3 quarters. The position peaked at $518K in Q2 2018. 182 funds tracked by Wall St. Rank hold EGRX as of Q1 2019.

  • Hartford Investment Management Co (HIMCO) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 6,420 Eagle Pharmaceuticals, Inc. shares in Q1 2019, an estimated $259K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
  • Hartford Investment Management Co (HIMCO)'s Eagle Pharmaceuticals, Inc. position peaked at $518K in Q2 2018.
  • 182 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q1 2019, filed 29 Apr 2019.